Page 2 - Peter Greenleaf News Today

Otsuka Pharmaceutical has submitted an NDA to the Japanese Ministry of Health, Labour and Welfare for voclosporin to treat lupus nephritis (LN).

ROCKVILLE, Md. & EDMONTON, Alberta, November 13, 2023--Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan

Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Operator: Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

03.08.2023 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the three and six months ended June 30, 2023. Amounts are expressed in U.S. dollars. Total net revenue was $41.5 million for the three months ...

StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) in a research report report published on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada lifted their price objective on shares of Aurinia Pharmaceuticals from $11.00 to $13.00 and gave the company an […]

Aurinia Pharmaceuticals Inc. today announced voting results for its annual general meeting of shareholders held on May 17, 2023. Shareholders re-elected six of eight incumbent directors to the... | May 17, 2023

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) shares traded down 6.4% during trading on Tuesday . The stock traded as low as $10.09 and last traded at $10.18. 1,176,587 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 3,305,892 shares. The stock had previously closed at $10.88. […]

Nicolet Advisory Services LLC bought a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 18,297 shares of the biotechnology company’s stock, valued at approximately $152,000. Several […]

Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.18) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.05, Briefing.com reports. Aurinia Pharmaceuticals had a negative net margin of 65.90% and a negative return on equity of 23.17%. The firm had revenue of […]